The Fayetteville startup CardioWise Inc. is continuing to reach its target offering of $2 million.
The company, which has developed cardiac analysis software, began selling shares in March 2014, according to its filing with the U.S. Securities & Exchange Commission.
As of late last month, the company reported the total sale of $620,000 worth of shares with $1.38 million remaining.
The minimum investment is $25,000.
CardioWise said in the filing that it intends for the offering to last more than a year, and the company has nine investors.
CardioWise’s software, Multiparametric Strain Analysis, analyzes the three-dimensional motion of the heart acquired from cardiac MRI images. It then compares the analysis to the motion of a normal heart model.
Incorporated in 2012, CardioWise is a portfolio firm of VIC Technology Venture Development on the campus of the University of Arkansas’ Arkansas Research & Technology Park.